What is the funding round name?
We are raising a Pre-seed Round to launch eMedAlert mobile app, integrate smartwatch compatibility, and scale user acquisition.
What is the amount of capital seeking?
Targeted amount: $350,000, possible in two instalments. Type of offering: 30% Equity.
Who are your Lead Investors? Please provide a copy of their due diligence.
No lead investor has been finalized yet. Discussions are ongoing with potential angels and early-stage funds. Due diligence materials will be provided upon formal commitment. We are in advanced conversations with experienced angel investors familiar with health-tech startups.
What is the previous capital raised
$50k, our own funds.
What is the amount of capital seeking
Targeted amount: $350,000, possible in two instalments.
How much of this round is already committed?
At this stage, no formal commitments have been secured; we are actively engaging with angel investors and early-stage funds. We are open to equity negotiation with serious investors, aiming to create a partnership that aligns incentives and maximizes growth for eMedAlert.
One line pitch
eMedAlert is an AI-powered medical prevention and automatic alerting platform and app.
One phrase pitch
eMedAlert is a medical prevention and automatic alerting application, which combines AI & Machine Learning for early detection of medical risks, wearables for continuous monitoring and instant alerting, and Telemedicine services.
Current year’s revenue
No revenue yet. Pre-revenue funding.
Monthly burn rate
Projected monthly burn rate post-launch: $8,000 (covering product development, marketing, hosting, and operations).
Estimate of capital required to take company through an exit
We estimate a total of $3M–$5M in growth capital (through Seed, Series A, and potential Series B rounds) will be required to reach scale and position the company for a strategic exit.
MRR (Monthly Recurring Revenue)
Since eMedAlert is pre-revenue, your MRR (Monthly Recurring Revenue) = $0, so the Annualized Run Rate = $0 × 12 = $0.
Currently $0, as eMedAlert is pre-revenue. Revenue generation will begin after the Seed round, once the mobile app is launched on Google Play, smartwatch compatibility is integrated, and user acquisition campaigns are executed.
Optional addition (if the form allows for a note)
Based on our financial model, we project reaching an MRR of [$X] within 12 months post-launch, translating to an annualized run rate of [$X × 12].
Describe your exit strategy for investors
1. Strategic Acquisition (M&A)
— Strategic acquisition by large healthcare /insurtech /telemedicine companies (e.g., Philips, Teladoc, Apple Health). Companies that want prevention and predictive medical data.
2. IPO / SPAC
— Listing on the stock exchange after international scaling and consolidation of recurring revenues. IPO option once user base exceeds 100,000+ subscribers globally.
3. Buy-back
— Share buyback by the founders or the company, for investors who want an early exit.
4. Secondary Sale
— Selling the stake to other investors/growth funds or strategic partners. — Investor ROI targeted through recurring revenue, international scaling, and data-driven healthcare partnerships.
Pre-money valuation:
$1.8M–$2.2M, reflecting our MVP traction, early user engagement, and high-growth market potential.
Post-money valuation:
$2.15M–$2.55M, based on a $350k Seed round and pre-money valuation of $1.8M–$2.2M, reflecting MVP traction and market potential.
We are open to equity negotiation with investors, aiming to create a partnership that aligns incentives and maximizes growth for eMedAlert.